Federated Hermes Portfolio holdings
AUM
$53.1B
This Quarter Return
+6.3%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$31.9B
AUM Growth
+$31.9B
(+6.5%)
Cap. Flow
+$584M
Cap. Flow
% of AUM
1.83%
Top 10 Holdings %
Top 10 Hldgs %
19.72%
Holding
2,076
New
329
Increased
702
Reduced
834
Closed
116
Top Buys
| 1 |
Illumina
ILMN
|
$176M |
| 2 |
Williams Companies
WMB
|
$153M |
| 3 |
Ventas
VTR
|
$137M |
| 4 |
Healthpeak Properties
DOC
|
$100M |
| 5 |
Apple
AAPL
|
$84.1M |
Top Sells
| 1 |
AstraZeneca
AZN
|
$284M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$108M |
| 3 |
HSH
HILLSHIRE BRANDS CO
HSH
|
$86.3M |
| 4 |
Fortune Brands Innovations
FBIN
|
$83.8M |
| 5 |
AGN
ALLERGAN INC
AGN
|
$79.8M |
Sector Composition
| 1 | Healthcare | 15.6% |
| 2 | Consumer Staples | 12.46% |
| 3 | Energy | 12.05% |
| 4 | Financials | 8.62% |
| 5 | Utilities | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AbbVie
ABBV
$376B
| $244M | 0.76% |
4,317,840
+268,769
| +7% | +$15.2M |
|
27
Eli Lilly
LLY
$659B
| $231M | 0.72% |
3,714,961
+27,532
| +0.7% | +$1.71M |
|
|
RDS.B
28
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $227M | 0.71% |
2,608,560
+66,473
| +3% | +$5.78M |
|
29
GSK
GSK
$79.3B
| $227M | 0.71% |
4,235,435
+869,696
| +26% | +$46.5M |
|
|
30
Illumina
ILMN
$15.4B
| $215M | 0.68% |
1,205,584
+988,006
| +454% | +$176M |
|
31
LyondellBasell Industries
LYB
$17.9B
| $204M | 0.64% |
2,085,111
-83,939
| -4% | -$8.2M |
|
32
Halliburton
HAL
$19.2B
| $203M | 0.64% |
2,851,848
-175,387
| -6% | -$12.5M |
|
33
American Electric Power
AEP
$58.6B
| $190M | 0.6% |
3,414,779
+27,839
| +0.8% | +$1.55M |
|
34
Procter & Gamble
PG
$368B
| $187M | 0.59% |
2,377,247
+571,899
| +32% | +$44.9M |
|
35
DexCom
DXCM
$29.5B
| $177M | 0.55% |
4,450,848
-22,917
| -0.5% | -$909K |
|
36
Alkermes
ALKS
$5.11B
| $176M | 0.55% |
3,499,276
-55,315
| -2% | -$2.78M |
|
37
JPMorgan Chase
JPM
$822B
| $173M | 0.54% |
2,995,471
-475,946
| -14% | -$27.4M |
|
38
Pfizer
PFE
$143B
| $157M | 0.49% |
5,305,465
-508,840
| -9% | -$15.1M |
|
39
PepsiCo
PEP
$205B
| $156M | 0.49% |
1,745,937
+9,603
| +0.6% | +$858K |
|
|
SLXP
40
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $150M | 0.47% |
1,213,894
-215,278
| -15% | -$26.6M |
|
|
CBST
41
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $147M | 0.46% |
2,100,334
-432,994
| -17% | -$30.2M |
|
42
Corning
GLW
$59.1B
| $135M | 0.42% |
6,140,399
-37,527
| -0.6% | -$824K |
|
|
SLCA
43
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $133M | 0.42% |
2,390,736
-535,630
| -18% | -$29.7M |
|
44
Biogen
BIIB
$21B
| $132M | 0.42% |
419,779
-4,158
| -1% | -$1.31M |
|
|
DYAX
45
DELISTED
DYAX CORPORATION
DYAX
| $130M | 0.41% |
13,584,600
-1,059,137
| -7% | -$10.2M |
|
46
Bristol-Myers Squibb
BMY
$98.4B
| $129M | 0.41% |
2,662,800
-4,212
| -0.2% | -$204K |
|
47
Hartford Financial Services
HIG
$37.1B
| $128M | 0.4% |
3,573,439
+436,858
| +14% | +$15.6M |
|
48
NXP Semiconductors
NXPI
$58.7B
| $126M | 0.4% |
1,904,700
-173,200
| -8% | -$11.5M |
|
49
Gilead Sciences
GILD
$140B
| $122M | 0.38% |
1,473,732
+22,973
| +2% | +$1.9M |
|
50
CVS Health
CVS
$94B
| $114M | 0.36% |
1,515,334
-13,676
| -0.9% | -$1.03M |
|